The role of first-trimester HbA1c in the early detection of gestational diabetes
Valadan M, Bahramnezhad Z, Golshahi F, Feizabad E
BMC Pregnancy Childbirth. 2022;22(1):71.
Leggi
Gastric bypass versus sleeve gastrectomy in type 2 diabetes: effects on hepatic steatosis and fibrosis. A randomized controlled trial
Seeberg KA, Borgeraas H, Hofsø D, et al.
Ann Intern Med. 2022;175(1):74-83
Leggi
Empagliflozin, health status, and quality of life in patients with heart failure and preserved ejection fraction: the EMPEROR-Preserved trial
Butler J, Filippatos G, Siddiqi TJ, et al.
Circulation. 2022;145(3):184-193
Leggi
Serial assessment of high-sensitivity cardiac troponin and the effect of dapagliflozin in patients with heart failure with reduced ejection fraction: an analysis of the DAPA-HF trial
Berg DD, Docherty KF, Sattar N, et al.
Circulation. 2022;145(3):158-169
Leggi
Risk for newly diagnosed diabetes >30 Days After SARS-CoV-2 infection among persons aged <18 years - United States, March 1, 2020-June 28, 2021
Barrett CE, Koyama AK, Alvarez P, et al.
MMWR Morb Mortal Wkly Rep. 2022;71(2):59-65.
Leggi
NOTA AIFA 100 – Prescrizione degli inibitori del SGLT2, degli agonisti recettoriali del GLP1, degli inibitori del DPP4 e loro associazioni nel trattamento del diabete mellito tipo 2
25 gennaio 2022
Leggi
Sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide-1 receptor agonists, and dipeptidyl peptidase-4 inhibitors, and risk of hospitalization
Lyu B, Grams ME, Chang A, et al.
Am J Cardiol. 2022;165:124-130.
Leggi
Glycemic outcomes in baseline hemoglobin a1c subgroups in the International Diabetes Closed-Loop (iDCL) Trial
Ekhlaspour L, Town MA, Raghinaru D, et al.
Diabetes Technol Ther. Pub. online 12 January 2022
Leggi
Risk factor analysis for type 2 diabetic patients about hypoglycemia using continuous glucose monitoring: Results from a prospective observational study
Uemura F, Okada Y, Mita T, et al.
Diabetes Technol Ther. Pub. online 20 January 2022.
Leggi